AIDS Treatment News logo      

June 25, 2009

New Ideas About Reaching HIV Sanctuaries in the Body

"A joint U.S. and Canadian team of researchers say they have confirmed how specific immune cells serve as a protected reservoir of HIV, despite potent antiretroviral (ARV) therapy. They also offer ideas for eradicating that sanctuary of cells—and the virus along with it—in a study published online June 21 in Nature Medicine."

Read more in POZ, June 22, 2009.

1 comments:

Spin said...

Observational HIV Study
The following is the conclusion of the Observational Study of HIV patients using CHD-FA as active ingredient:

◦It can therefore be concluded that The Product is well tolerated in patients suffering from HIV.
◦The Product caused no liver or renal toxicity in these patients.
◦The Product caused a statistically significant reduction of the viral loads of the pre-ART HIV positive patients. This effect needs further extrapolation in a randomized, double blind, controlled study.
◦The pre- ART HIV patients on The Product reported a significant improvement of their well being proving the HA hypothesis that The Product does improve health related outcomes in patients with HIV.
◦This study therefore supports further investigations into these effects in a more robust and interventional manner in order to test the validity of The Product as a possible complementary product to boost well being in HIV patients

Secomet

Read more: http://fulhold.com/pics/observational_HIV_study.pdf